SectorBiological Technology
Established Date21/09/2006
Listing Date28/01/2015
ExchangeNASDAQ Stock Exchange
Full-time Employees1189
Fiscal Year Ends31/12
Security TypeDepository Receipts (Ordinary Shares)
Office addressTuborg Boulevard 12, DK-2900 Hellerup, Denmark
Business
IntroductionAscendis Pharma A/s was established on September 21, 2006. The company is a clinical-stage biopharmaceutical company that uses its TransCon technology to develop a pipeline of optimal long-acting drug therapies to address significant unmet medical needs in a large market. The company is developing its lead product candidate, TransCon human growth hormone or growth hormone TransCon, once a week for the treatment of growth hormone deficiency and other diseases.
